BlackRock’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,389,788
| Closed | -$428M | – | 5470 |
|
|
2024
Q4 | $428M | Buy |
8,389,788
+64,682
| +0.8% | +$3.3M | 0.01% | 1183 |
|
|
2024
Q3 | $343M | Sell |
8,325,106
-38,565
| -0.5% | -$1.59M | 0.01% | 1332 |
|
|
2024
Q2 | $403M | Sell |
8,363,671
-118,708
| -1% | -$5.72M | 0.01% | 1145 |
|
|
2024
Q1 | $407M | Buy |
8,482,379
+1,785,781
| +27% | +$85.7M | 0.01% | 1172 |
|
|
2023
Q4 | $435M | Buy |
6,696,598
+210,676
| +3% | +$13.7M | 0.01% | 1109 |
|
|
2023
Q3 | $424M | Buy |
6,485,922
+100,116
| +2% | +$6.55M | 0.01% | 1013 |
|
|
2023
Q2 | $371M | Buy |
6,385,806
+733,738
| +13% | +$42.7M | 0.01% | 1136 |
|
|
2023
Q1 | $349M | Sell |
5,652,068
-19,032
| -0.3% | -$1.18M | 0.01% | 1157 |
|
|
2022
Q4 | $360M | Buy |
5,671,100
+255,304
| +5% | +$16.2M | 0.01% | 1101 |
|
|
2022
Q3 | $393M | Buy |
5,415,796
+858,266
| +19% | +$62.3M | 0.01% | 972 |
|
|
2022
Q2 | $310M | Buy |
4,557,530
+2,236,840
| +96% | +$152M | 0.01% | 1199 |
|
|
2022
Q1 | $210M | Buy |
2,320,690
+1,955
| +0.1% | +$177K | 0.01% | 1628 |
|
|
2021
Q4 | $212M | Buy |
2,318,735
+93,071
| +4% | +$8.49M | 0.01% | 1690 |
|
|
2021
Q3 | $181M | Buy |
2,225,664
+424,329
| +24% | +$34.4M | 0.01% | 1780 |
|
|
2021
Q2 | $168M | Buy |
1,801,335
+700,745
| +64% | +$65.4M | ﹤0.01% | 1892 |
|
|
2021
Q1 | $118M | Buy |
1,100,590
+507,832
| +86% | +$54.3M | ﹤0.01% | 2084 |
|
|
2020
Q4 | $51.7M | Buy |
592,758
+47,455
| +9% | +$4.14M | ﹤0.01% | 2406 |
|
|
2020
Q3 | $37.6M | Buy |
+545,303
| New | +$37.6M | ﹤0.01% | 2407 |
|